Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Lamotrigine Adjunctive Therapy to Lithium and Divalproex in Depressed Patients with Rapid Cycling Bipolar Disorder and a Recent Substance Use Disorder: A 12-week, Double-Blind, Placebo-Controlled Pilot Study
1
x
$
30.00
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
1
x
$
30.00
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
1
x
$
30.00
Philip T. Ninan, MD: Pharmacokinetically Induced Benzodiazepine Withdrawal
1
x
$
30.00
Karen Dineen Wagner, MD, PhD: Management of Bipolar Disorder in Children and Adolescents
1
x
$
30.00
Escitalopram: A Second-Generation SSRI
1
x
$
0.00
Depression Treatment: A Lifelong Commitment?
1
x
$
30.00
Psychopharmacology Bulletin VOL 37 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Bereavement During a Course of TMS for MDD: A Case Report
1
x
$
30.00
Valproate-Autism Labyrinth
1
x
$
30.00
Consecuencias psicosociales de la depresión adolescente
1
x
$
0.00
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
1
x
$
30.00
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
View Cart
Checkout
Home
Bryun EA
“Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top